ReviewCancer

The p53 Pathway as a Target in Cancer Therapeutics: Obstacles and Promise

Science Translational Medicine  05 Jan 2011:
Vol. 3, Issue 64, pp. 64rv1
DOI: 10.1126/scitranslmed.3001366

Log in to view the full text

Navigate This Article

  1. Article
    1. Abstract
    2. Introduction
    3. The Bright Side of p53 in Cancer Therapeutics
    4. The Dark Side of p53 in Cancer Therapeutics
    5. Development of p53 Activators as Therapeutic Drugs
    6. Footnotes
    7. References and Notes
  2. Figures & Data
  3. Info & Metrics
  4. eLetters
  5. PDF